ToxStrategies, a portfolio company of Renovus Capital Partners, has acquired Clintrex Research Corporation

Buyer

Renovus Capital Partners

A lower middle market private equity firm specializing in the knowledge and talent industries.

Portfolio Company

ToxStrategies

A multidisciplinary scientific consulting firm that provides toxicological and epidemiological services to clients in the pharmaceutical, food and additives, consumer products, chemical, petrochemical, and pet sectors.

Seller

Clintrex Research Corporation

Provides scientific, clinical trial, operational, and regulatory assistance to pharmaceutical and biotech companies engaged in the development of new therapies for central nervous system disorders.